Davies MJ, Aronne LJ, Caterson ID, Thomsen AB, Jacobsen PB, Marso SP
Mounjaro is not approved for : Prevention or treatment of dementia or cognitive decline Type 1 diabetes Diabetic ketoacidosis Prescribing Mounjaro outside its licensed indications would be considered off-label use and is not supported by current UK regulatory or clinical guidelines
Rotate your injection sites each week to prevent irritation and lipodystrophy
Vomiting after most meals
Platforms like MeAgain centralize injection schedules, meal logs, hydration, and side effects, making it easier to spot correlations and compress trial-and-error from weeks to days
Consulting with healthcare providers is crucial to determine the most appropriate therapy for optimal outcomes